Showing results (1481-1490 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 8, 2016
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-AnalysisMing Yin, Monika Joshi, Richard P Meijer, et al.
The Oncologist|July 13, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaIan Cromwell, Dean A Regier, Stuart J Peacock, et al.
The Oncologist|July 13, 2016
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for ImprovementEduard Vrdoljak, Gyorgy Bodoky, Jacek Jassem, et al.
The Oncologist|July 13, 2016
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position StatementRomain Coriat, Thomas Walter, Benoît Terris, et al.
The Oncologist|July 13, 2016
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy StudiesSara Sheikhbahaei, Tyler J Trahan, Jennifer Xiao, et al.
The Oncologist|July 13, 2016
Breast Camps for Awareness and Early Diagnosis of Breast Cancer in Countries With Limited Resources: A Multidisciplinary Model From KenyaShahin Sayed, Zahir Moloo, Anthony Ngugi, et al.
The Oncologist|July 26, 2017
Development of Palliative Care in China: A Tale of Three CitiesZhenyu Yin, Jinxiang Li, Ke Ma, et al.
The Oncologist|August 12, 2017
Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in KenyaKathleen R Ragan, Natasha Buchanan Lunsford, Judith Lee Smith, et al.
The Oncologist|August 12, 2017
Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from ChinaJianbin Li, Shusen Wang, Yongsheng Wang, et al.
The Oncologist|September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H Ko, Patrick B Murphy, James D Peyton, et al.
Pageof 571